• Home
  • Time to prostate-specific antigen nadir after androgen suppression therapy for postoperative or postradiation PSA failure and risk of prostate cancer-specific mortality.

Time to prostate-specific antigen nadir after androgen suppression therapy for postoperative or postradiation PSA failure and risk of prostate cancer-specific mortality.

Author List
Chung CS, Chen MH, Cullen J, McLeod D, Carroll P, D'Amico AV
Publication
Urology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1460344
Publication Year
2008
PubMed ID
18242382
Publication Title
Chung CS, Chen MH, Cullen J, McLeod D, Carroll P, D'Amico AV. Time to prostate-specific antigen nadir after androgen suppression therapy for postoperative or postradiation PSA failure and risk of prostate cancer-specific mortality. Urology. 2008 Jan; 71(1):136-40.